1.
The over-all 3-and 5-year disease free actuarial survival rates were 42% and 33%.
3、5年生存率为40％和33％。
2.
The 3-year overall survival (OS) and disease free survival ( DFS) was 66. 3% and 59. 5% , respectively.
3年总生存率和无病生存率分别为66．3％和59．5％。
3.
The five-year survival rate (SR),disease free survival rate (DFSR) were 65 6% and 54 5%,respectively.
总的5年生存率、无瘤生存率分别为65．6％和54．5％。
4.
The 5 -year overall survival (OS) and disease free survival (DFS) were 89% and 73%,respectively.
全组5年总生存率和无病生存率分别为89%和73%。
5.
10-year survival rate and 10-year NED rate were 62.4% and 60.2%.
10年生存率、健在率分别为62.4%及60.2%。
6.
RESULTS: The median survival was 11 months, with a 3-year survival of 24%.
结果：平均生存时间是11个月，3年生存率为24％。
7.
The 3-years survival rates of the patients treated with IAD by flutamide and cascodex were(72.7%) and 80.0% respectively. The overall 3 years survival rates of IAD was 76.2%.
甲组3年生存率为72.7%,乙组为80.0%,总3年生存率为76.2%。
8.
Results Symptom relief rate was 90%. The overall actuarial 5year survival rate was 23.0±7.5% .
结果症状缓解率达90％左右，5年生存率23．0±7．5％。
9.
We calculate survival rate and evaluate the function of larynx according to the stage.
计算生存率和评估喉功能恢复情况。
10.
The 1, 3 and 5-year sur-vival rate were 40.8%.
全组1、3、5年生存率分别为40.80％、16.11％、11.39％;
11.
Results After treatment, the1_、2_ year_ survival rates were42.1%、31.6% respectively, median survival time10.5 months.
结果治疗后1、年生存率分别为421%316%,中位生存期105个月。
12.
The probability of survival is the reciprocal of fecundity.
生存的概率是生殖力的倒数。
13.
The Live Probabilities of a Special Double Type-insurance Risk Model with Interest
常利率下的特殊双险种风险模型的生存概率
14.
EOQ Model for Short-Life Products Under Stock-Dependent Selling Rate
存货影响销售率的短生命周期物品库存管理
15.
Discrete time survival analysis was used to estimate depressive events risk.
生存分离率用于分析抑郁症发病风险。
16.
And an increasing secular trend was observed both in urban and rural areas.
尿道下裂发生率存在逐年上升的趋势。
17.
The Survival Probability in Generalized Double Possion Risk Model;
广义双Poisson风险模型下的生存概率
18.
Some Results of Survival Probability in the Correlated Claims Model;
相关风险模型中生存概率的若干结果